Lactobacillus paracasei strain
US-12152232-B2 · Nov 26, 2024 · US
Probiotic and new biomarker
US10226492B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10226492-B2 |
| Application number | US-201515529079-A |
| Country | US |
| Kind code | B2 |
| Filing date | Nov 25, 2015 |
| Priority date | Nov 25, 2014 |
| Publication date | Mar 12, 2019 |
| Grant date | Mar 12, 2019 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The present invention relates to a new probiotic with immune modulating properties and to a new biomarker.
First claim
Opening claim text (preview).
The invention claimed is: 1. A probiotic formulation comprising at least one food-grade substance and at least one probiotic bacterial strain comprising at least one polynucleotide that has at least 95% sequence identity to: a polynucleotide sequence selected from the group consisting of SEQ ID NOs: 177, 183, 188, 205, 207, 219, 244, and 248, and/or a polynucleotide encoding a polypeptide with a sequence selected from the group consisting of SEQ ID NOs: 261, 267, 272, 289, 291, 303, 328, and 332. 2. A probiotic formulation according to claim 1 , comprising at least one further probiotic bacterial strain. 3. A probiotic formulation according to claim 1 , wherein the concentration of probiotic bacterial strains ranges from about 10 to about 50 weight percent and/or about 1 E+6 to about 1 E+12 colony forming units/ml of formulation. 4. A probiotic formulation according to claim 1 that is formed as part of a tablet or that is contained within a capsule. 5. A food product, a formulation for food enrichment, a food supplement, a nutraceutical formulation or a pharmaceutical formulation comprising a probiotic formulation according to claim 1 . 6. A container with a liquid volume between 0.5 and 50 ml comprising a probiotic formulation according to claim 1 . 7. A container with a liquid volume between 0.5 and 1000 ml comprising a food product, a formulation for food enrichment, a food supplement, a nutraceutical formulation or a pharmaceutical formulation according to claim 5 . 8. A probiotic formulation comprising at least one food-grade substance and a probiotic bacterial strain Lactobacillus plantarum TIFN 101with accession number CBS 138100.
Assignees
Inventors
Classifications
Immunostimulants · CPC title
Cells of the immune system · CPC title
Bacteria; Culture media therefor · CPC title
- A61K35/747Primary
Lactobacilli, e.g. L. acidophilus or L. brevis · CPC title
Bacteria or derivatives thereof, e.g. probiotics · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US10226492B2 cover?
- The present invention relates to a new probiotic with immune modulating properties and to a new biomarker.
- Who is the assignee on this patent?
- Dsm Ip Assets Bv
- What technology area does this patent fall under?
- Primary CPC classification A61K35/747. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Mar 12 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).